Advanced Accelerator Applications (AAAP) Reports Q3 Loss of EUR0.26/Share

Go back to Advanced Accelerator Applications (AAAP) Reports Q3 Loss of EUR0.26/Share

Advanced Accelerator Applications Reports 39% Sales Growth for Third Quarter 2017

November 17, 2017 7:39 AM EST

$3.9 Billion All Cash Proposed Tender Offer by Novartis

European Approval of Lutetium Lu 177 Dotatate* (Lutathera®) for GEP-NETs

Recent Highlights:

Sales for the third quarter of 2017 increased 39% compared to the third quarter of 2016NETSPOT® unit sales per month increased 14% (from 915 to 1040) from June to September 2017Entered into a Memorandum of Understanding with Novartis, pursuant to which Novartis proposes to make a $3.9 billion cash tender offer to acquire all the outstanding shares of AAAEuropean Commission approved marketing authorization... More